Founded and led by Dr. John Reveille, the UTHealth Spondyloarthritis program is committed to providing state-of-the-art care and conducting groundbreaking research for those affected by spondyloarthritis since 1999. Our physicians are faculty members of the McGovern Medical School and are board certified in Rheumatology. At the core of our program have been the hundreds of dedicated patients who have contributed to our understanding of these diseases. We are involved in one of the largest existing cohort of ankylosing spondylitis (AS) patients world-wide with thousands of participants with ankylosing spondylitis that has helped define the understanding of the pathogenesis, treatment and outcomes of this disease. In a true comprehensive, patient-oriented approach, we conduct research ranging from: molecular profiling of disease manifestations, understanding the patient experience through study of patient-reported outcomes abd capturing the disease burden through our longitudinal cohort and conducting both industry-sponsored and investigator-initiated clinical trials of treatments of spondyloarthritis.